PLEASANTON, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in products to treat cardiovascular disease, said today that it will be participating in the Bear Stearns 2007 Healthcare Conference on Tuesday, September 11.
Gary Burbach, president and chief executive officer, will provide an update on the company, beginning at 3 p.m., Eastern Daylight Time (12 p.m., Pacific Daylight Time).
The presentation will be available through the conference website http://cc.talkpoint.com/BEAR002/091007a_sc/?entity=thoratec and on the company’s website at http://www.thoratec.com.
Thoratec is a world leader in therapies to address advanced-stage heart failure. The company’s product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company’s websites at http://www.thoratec.com or http://www.itcmed.com.
Thoratec Corporation
CONTACT: David Smith, Executive Vice President, Chief Financial Officer ofThoratec Corporation, +1-925-847-8600; or Neal B. Rosen of Kalt RosenGroup-Ruder Finn West, +1-415-692-3058
